Canary Wharf to House Large Commercial Bio Labs

Canary Wharf's North Quay in the banking district is looking to house world's largest Big Pharma bio-labs formerly headquartered in Ukraine.

A densely populated residential area. With major transport links into the capital, London City Airport and a wet market. Sounds perfectly safe.

 The densely populated Canary Wharf district from the south peninsula.
The densely populated Canary Wharf district from the south peninsula.

Along a major river flowing into a major capital, major banking and business districts with underground and railway stations, along with a new Elizabeth tube stop.

A low wage earning residential immigrant community of Bangladeshi and Eastern Europe (Czech, Latvian and Polish) tightly packed outside the 128 acre site in Tower Hamlets.

The estate, privately owned, has no 'issues with the locals' setting up Europe's largest bio-lab for hire space to develop new pathogens.

What is a Wet Lab?

A wet lab, sometimes referred to as an experimental lab, where drugs, chemicals and other types of biological matter are analysed and tested.

These labs are designed, constructed and controlled to avoid spillage and contamination. Much like the NIH funded bio lab in the Chinese city of Wuhan.

Dutch developer Kadans Science Partner forwarded plans to Canary Wharf Group (CWG) for a ‘life sciences’ building in the district.

The project is expected to cost about £500 million and become Europe's largest wet lab facility in a 3.3 hectare development on the Wharf's North Quay.

The new development will be on a similar scale to the Crick Institute, the biomedical research facility established by London universities in 2016. However, the Canary Wharf development will focus on commercial applications.

Howard Dawber Head of Strategy at CWG, said "There is huge demand for this." Adding, labs in London were already at capacity with a vacancy rate of just 4% in Oxford and 1% in Cambridge.

Banksters to Bio Labsters

The dock lands were built on 30 years ago to expand the financial services operations of big banks east from The City of London.

It comes after Covid-19 lockdowns and work restrictions battered foot-flow, which averaged around 33,000 visitors daily through the tube station gates to under 10%.

The resulting drop shuttered many of the shops in its underground mall and roadside level restaurants. CWG Chief Executive Shobi Khan was quoted in the Financial Times:

“We’re down to 50% tenants and we’re broadening out to health and life sciences now”.

Potential Resident Tenants for North Quay Bio Labs

Nearly all of the world's largest pharmaceutical companies are either headquartered or running ‘clinical trials’ in Kiev, Ukraine.

Couriers are able to run bio pathogens from out of country under full diplomatic immunity.

If the Canary Wharf Group Sales Team are reading, here's a list of multinational pharmaceutical companies looking for space since President Putin sent Russian troops take out the biological wet labs.

GlaxoSmithKline has 236 sites, may have up to 26 labs in Ukraine alone in phase 3 study of Otilimab in patients with rheumatoid arthritis.

AstraZeneca has up to 20 active trials in Ukraine.

Sanofi has at least two studies underway in Ukraine for the Regeneron-partnered med Dupixent.

Karuna conducts Intra-Cellular Therapies, has about 36% of sites for the bipolar depression med Caplyta in Ukraine and Russia. The therapy is being tested in borderline personality disorder and major depressive disorder.

Incyte has "heavy exposure" for its oral PD-L1 program in solid tumors, with 70% of the sites in Ukraine.

Veru is expected to "maintain timelines" on its study of breast cancer treatment Enobosarm.

TG Therapeutics has a phase 3 extension study ongoing at 20 of 85 trial sites in Ukraine. It won't experience any "meaningful impact" as it already asked the FDA to approve its drug Ublituximab in patients with relapsing multiple sclerosis.

Others operating clinical trials in Ukraine include:

Atai Life Sciences
Blueprint Medicines
Global Blood Therapeutics
Gilead – Who paid $259M to Doctors & Hospitals to promote Hepatitis C elimination project despite at least 249 patient deaths.fn
PTC Therapeutics

Canary Wharf Group may also want to follow up with Venture Capital firms and Investment Houses also "dis-engaging with Russian industry".

• RA Capital
• Atlas Venture
• Third Rock Ventures

From what I observe; Russia feels they had to make multiple incursions into Ukraine because:

  1. 26 gain of function bio-labs, all with full diplomatic immunity for “Big Pharma” on their border.
  2. Neo-Nazi groups involved in the Ukrainian Army and Government since US led 2013 coup.
  3. The Ukraine government broke the Minsk Accord.

26 Ukrainian Bio Labs on Russian Border

"Oh, those bio labs..."

Former Under Secretary of State for Political Affairs, Victoria Nuland, lamented Russia for destroying in the mainstream media which previously been denied to exist. The narrative then shifted to - there are no bioweapons in the Ukranian labs.

Article 8 of The Rome Statute of the International Criminal Court defines biological experiments as war crimes. The US is not party to the international treaty, therefore cannot be held accountable.

Nyland, was one of the famous Neo-Cons who orchestrated the Ukranian coup in 2013, installing Arseniy Yatsenyuk as Prime Minister and Petro Poroshenko as President.

A leaked 2013 call in which Nuland discusses regime change, who to replace Yanukovych with and install a new handpicked Ukrainian Government once the Obama Administration had backed violent coup of EuroMaidan (Nov 2013 - Feb 2014) ended.

Nyland Leaked Call on Installing Ukrainian Govt pt.1
Nyland Leaked Call on Installing Ukrainian Govt pt.2

Neo Nazi's in Ukraine Army and Government

On 16 December 2021, the entire UN voted on an anti-Nazi resolution. The vote was 130-2. Those two countries were Ukraine and the US.

UN vote on Combating glorification of Nazism, neo-Nazism and other Practices:Item 72a - A/76/460